Follow the JW생명과학 stock price and the full insider trade history of the company, a listed equity based in South Korea. Shares are listed on the KR market, under the supervision of DART (FSS). Operating in the Health Care sector, JW생명과학 has recorded 15 insider filings. Market capitalisation: €170.9bn. The latest transaction was disclosed on 10 July 2026 (Purchase). Among the most active insiders: FILLIMITED. The full history is free.
15
Insider Decl.
n/a
Thresholds
n/a
9 ops.
Buy Volume
n/a
n/a
Sell Volume
10Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 1,653 of 29,063 companies
78.1
score / 100
Value
93
Quality
64
FCF yld15%
Earn yld16%
EV/EBITDA4.4x
ROE14%
Gross mgn28%
Net mgn11%
Debt/EBITDA1.0x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
JW Life Science es una empresa del sector de la salud y farmacéutico, que cotiza en el mercado XKRX. Se centra en el desarrollo de productos farmacéuticos y biotecnológicos.